Table of Contents Author Guidelines Submit a Manuscript
Evidence-Based Complementary and Alternative Medicine
Volume 2013, Article ID 636597, 10 pages
http://dx.doi.org/10.1155/2013/636597
Research Article

7,3′,4′-Trihydroxyisoflavone Ameliorates the Development of Dermatophagoides farinae-Induced Atopic Dermatitis in NC/Nga Mice

1School of Food Science and Biotechnology, Kyungpook National University, Daegu 702-701, Republic of Korea
2WCU Biomodulation Major, Department of Agricultural Biotechnology, Seoul National University, Seoul 151-921, Republic of Korea
3Advanced Institutes of Convergence Technology, Seoul National University, Suwon 443-270, Republic of Korea
4Skin Research Institute, Amorepacific Corporation R&D Center, Yongin-si, Gyeonggi-do 341-1, Republic of Korea
5Research Institute of Bio Food Industry, Institute of Green Bio Science and Technology, Seoul National University, Pyeongchang 232-916, Republic of Korea

Received 24 June 2013; Accepted 7 October 2013

Academic Editor: Xiu-Min Li

Copyright © 2013 Bo-Bae Kim et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. S. Dold, M. Wjst, E. von Mutius, P. Reitmeir, and E. Stiepel, “Genetic risk for asthma, allergic rhinits, and atopic dermatitis,” Archives of Disease in Childhood, vol. 67, no. 8, pp. 1018–1022, 1992. View at Google Scholar · View at Scopus
  2. H. Suto, H. Matsuda, K. Mitsuishi et al., “NC/Nga mice: a mouse model for atopic dermatitis,” International Archives of Allergy and Immunology, vol. 120, no. 1, pp. 70–75, 1999. View at Publisher · View at Google Scholar · View at Scopus
  3. G. Wu, L. Li, G. H. Sung et al., “Inhibition of 2,4-dinitrofluorobenzene-induced atopic dermatitis by topical application of the butanol extract of Cordyceps bassiana in NC/Nga mice,” Journal of Ethnopharmacology, vol. 134, no. 2, pp. 504–509, 2011. View at Publisher · View at Google Scholar · View at Scopus
  4. T. Oshio, Y. Sasaki, M. Funakoshi-Tago et al., “Dermatophagoides farinae extract induces severe atopic dermatitis in NC/Nga mice, which is effectively suppressed by the administration of tacrolimus ointment,” International Immunopharmacology, vol. 9, no. 4, pp. 403–411, 2009. View at Publisher · View at Google Scholar · View at Scopus
  5. Y. Mutou, Y. Ibuki, and S. Kojima, “Immunomodulatory effects of ultraviolet B irradiation on atopic dermatitis in NC/Nga mice,” Photodermatology Photoimmunology and Photomedicine, vol. 23, no. 4, pp. 135–144, 2007. View at Publisher · View at Google Scholar · View at Scopus
  6. E. V. Ponte, J. A. Rizzo, and A. A. Cruz, “Interrelationship among asthma, atopy, and helminth infections,” Jornal Brasileiro de Pneumologia, vol. 33, no. 3, pp. 335–342, 2007. View at Publisher · View at Google Scholar · View at Scopus
  7. H. Mastuda, T. Morikawa, K. Ueda, H. Managi, and M. Yoshikawa, “Structural requirements of flavonoids for inhibition of antigen-Induced degranulation, TNF-α and IL-4 production from RBL-2H3 cells,” Bioorganic and Medicinal Chemistry, vol. 10, no. 10, pp. 3123–3128, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. M. J. Cork, D. A. Robinson, Y. Vasilopoulos et al., “New perspectives on epidermal barrier dysfunction in atopic dermatitis: gene-environment interactions,” Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 3–21, 2006. View at Publisher · View at Google Scholar · View at Scopus
  9. S. K. Jeong, H. J. Kim, J. K. Youm et al., “Mite and cockroach allergens activate protease-activated receptor 2 and delay epidermal permeability barrier recovery,” Journal of Investigative Dermatology, vol. 128, no. 8, pp. 1930–1939, 2008. View at Publisher · View at Google Scholar · View at Scopus
  10. M. Steinhoff, U. Neisius, A. Ikoma et al., “Proteinase-activated receptor-2 mediates itch: a novel pathway for pruritus in human skin,” Journal of Neuroscience, vol. 23, no. 15, pp. 6176–6180, 2003. View at Google Scholar · View at Scopus
  11. J. P. Hachem, E. Houben, D. Crumrine et al., “Serine protease signaling of epidermal permeability barrier homeostasis,” Journal of Investigative Dermatology, vol. 126, no. 9, pp. 2074–2086, 2006. View at Publisher · View at Google Scholar · View at Scopus
  12. J. A. McGrath and J. Uitto, “The filaggrin story: novel insights into skin-barrier function and disease,” Trends in Molecular Medicine, vol. 14, no. 1, pp. 20–27, 2008. View at Publisher · View at Google Scholar · View at Scopus
  13. B. E. Kim and D. Y. M. Leung, “Epidermal barrier in atopic dermatitis,” Allergy, Asthma and Immunology Research, vol. 4, no. 1, pp. 12–16, 2012. View at Publisher · View at Google Scholar · View at Scopus
  14. C. N. A. Palmer, A. D. Irvine, A. Terron-Kwiatkowski et al., “Common loss-of-function variants of the epidermal barrier protein filaggrin are a major predisposing factor for atopic dermatitis,” Nature Genetics, vol. 38, no. 4, pp. 441–446, 2006. View at Publisher · View at Google Scholar · View at Scopus
  15. G. M. O'Regan, A. Sandilands, W. H. I. McLean, and A. D. Irvine, “Filaggrin in atopic dermatitis,” Journal of Allergy and Clinical Immunology, vol. 124, no. 3, pp. R2–R6, 2009. View at Publisher · View at Google Scholar · View at Scopus
  16. J. M. Spergel, E. Mizoguchi, H. Oettgen, A. K. Bhan, and R. S. Geha, “Roles of T(H)1 and T(H)2 cytokines in a murine model of allergic dermatitis,” Journal of Clinical Investigation, vol. 103, no. 8, pp. 1103–1111, 1999. View at Google Scholar · View at Scopus
  17. U. Herz, R. Bunikowski, and H. Renz, “Role of T cells in atopic dermatitis. New aspects on the dynamics of cytokine production and the contribution of bacterial superantigens,” International Archives of Allergy and Immunology, vol. 115, no. 3, pp. 179–190, 1998. View at Publisher · View at Google Scholar · View at Scopus
  18. D. Vercelli and R. S. Geha, “Regulation of isotype switching,” Current Opinion in Immunology, vol. 4, no. 6, pp. 794–797, 1992. View at Publisher · View at Google Scholar · View at Scopus
  19. R. I. Tepper, D. A. Levinson, B. Z. Stanger, J. Campos-Torres, A. K. Abbas, and P. Leder, “IL-4 induces allergic-like inflammatory disease and alters T cell development in transgenic mice,” Cell, vol. 62, no. 3, pp. 457–467, 1990. View at Publisher · View at Google Scholar · View at Scopus
  20. G. G. Brusselle, J. C. Kips, J. H. Tavernier et al., “Attenuation of allergic airway inflammation in IL-4 deficient mice,” Clinical and Experimental Allergy, vol. 24, no. 1, pp. 73–80, 1994. View at Publisher · View at Google Scholar · View at Scopus
  21. K. Pałgan and Z. Bartuzi, “The role of flavonoids in asthma,” Postępy Dermatologii i Alergologii, vol. 28, pp. 396–401, 2011. View at Google Scholar
  22. K. Yasui, H. Ikemoto, K. Taguchi et al., “The clinical and immunomodulatory effects of green soybean extracts,” Food Chemistry, vol. 138, no. 4, pp. 2300–2305, 2013. View at Publisher · View at Google Scholar
  23. Y. Miyake, S. Sasaki, Y. Ohya et al., “Soy, isoflavones, and prevalence of allergic rhinitis in Japanese women: the Osaka maternal and child health study,” Journal of Allergy and Clinical Immunology, vol. 115, no. 6, pp. 1176–1183, 2005. View at Publisher · View at Google Scholar · View at Scopus
  24. T. Zhang, W. Pan, M. Takebe, B. Schofield, H. Sampson, and X. M. Li, “Therapeutic effects of a fermented soy product on peanut hypersensitivity is associated with modulation of T-helper type 1 and T-helper type 2 responses,” Clinical and Experimental Allergy, vol. 38, no. 11, pp. 1808–1818, 2008. View at Publisher · View at Google Scholar · View at Scopus
  25. A. C. Eldridge and W. F. Kwolek, “Soybean isoflavones: effect of environment and variety on composition,” Journal of Agricultural and Food Chemistry, vol. 31, no. 2, pp. 394–396, 1983. View at Google Scholar · View at Scopus
  26. J. Chun, G. M. Kim, K. W. Lee et al., “Conversion of isoflavone glucosides to aglycones in soymilk by fermentation with lactic acid bacteria,” Journal of Food Science, vol. 72, no. 2, pp. M39–M44, 2007. View at Publisher · View at Google Scholar · View at Scopus
  27. T. Sakai, M. Kogiso, K. Mitsuya, T. Komatsu, and S. Yamamoto, “Genistein suppresses development of spontaneous atopic-like dermatitis in NC/Nga mice,” Journal of Nutritional Science and Vitaminology, vol. 52, no. 4, pp. 293–296, 2006. View at Google Scholar · View at Scopus
  28. D. E. Lee, K. W. Lee, S. Byun et al., “7,3′,4′-trihydroxyisoflavone, a metabolite of the soy isoflavone Daidzein, suppresses ultraviolet B-induced skin cancer by targeting Cot and MKK4,” Journal of Biological Chemistry, vol. 286, no. 16, pp. 14246–14256, 2011. View at Publisher · View at Google Scholar · View at Scopus
  29. Y. L. Lo, W. Wang, and C. T. Ho, “7,3′,4′-trihydroxyisoflavone modulates multidrug resistance transporters and induces apoptosis via production of reactive oxygen species,” Toxicology, vol. 302, no. 2-3, pp. 221–232, 2012. View at Publisher · View at Google Scholar
  30. S. E. Kulling, D. M. Honig, and M. Metzler, “Oxidative metabolism of the soy isoflavones daidzein and genistein in humans in vitro and in vivo,” Journal of Agricultural and Food Chemistry, vol. 49, no. 6, pp. 3024–3033, 2001. View at Google Scholar · View at Scopus
  31. K. M. Atherton, E. Mutch, and D. Ford, “Metabolism of the soyabean isoflavone daidzein by CYP1A2 and the extra-hepatic CYPs 1A1 and 1B1 affects biological activity,” Biochemical Pharmacology, vol. 72, no. 5, pp. 624–631, 2006. View at Publisher · View at Google Scholar · View at Scopus
  32. H. Matsuoka, N. Maki, S. Yoshida et al., “A mouse model of the atopic eczema/dermatitis syndrome by repeated application of a crude extract of house-dust mite Dermatophagoides farinae,” Allergy, vol. 58, no. 2, pp. 139–145, 2003. View at Publisher · View at Google Scholar · View at Scopus
  33. J. Ring, M. Mhrenschlager, and S. Weidinger, “Molecular genetics of atopic eczema,” Chemical Immunology and Allergy, vol. 96, pp. 24–29, 2012. View at Publisher · View at Google Scholar · View at Scopus
  34. S. E. Kulling, L. Lehmann, and M. Metzler, “Oxidative metabolism and genotoxic potential of major isoflavone phytoestrogens,” Journal of Chromatography B, vol. 777, no. 1-2, pp. 211–218, 2002. View at Publisher · View at Google Scholar · View at Scopus
  35. N. G. Coldham and M. J. Sauer, “Pharmacokinetics of [14C]genistein in the rat: gender-related differences, potential mechanisms of biological action, and implications for human health,” Toxicology and Applied Pharmacology, vol. 164, no. 2, pp. 206–215, 2000. View at Publisher · View at Google Scholar · View at Scopus
  36. T. Izumi, M. K. Piskula, S. Osawa et al., “Soy isoflavone aglycones are absorbed faster and in higher amounts than their glucosides in humans,” Journal of Nutrition, vol. 130, no. 7, pp. 1695–1699, 2000. View at Google Scholar · View at Scopus
  37. S. Weidinger, T. Illig, H. Baurecht et al., “Loss-of-function variations within the filaggrin gene predispose for atopic dermatitis with allergic sensitizations,” Journal of Allergy and Clinical Immunology, vol. 118, no. 1, pp. 214–219, 2006. View at Publisher · View at Google Scholar · View at Scopus
  38. C. Ebeling, T. Lam, J. R. Gordon, M. D. Hollenberg, and H. Vliagoftis, “Proteinase-activated receptor-2 promotes allergic sensitization to an inhaled antigen through a TNF-mediated pathway,” Journal of Immunology, vol. 179, no. 5, pp. 2910–2917, 2007. View at Google Scholar · View at Scopus
  39. D. Hijnen, E. Nijhuis, M. de Bruin-Weller et al., “Differential expression of genes involved in skin homing, proliferation, and apoptosis in CD4+ T cells of patients with atopic dermatitis,” Journal of Investigative Dermatology, vol. 125, no. 6, pp. 1149–1155, 2005. View at Publisher · View at Google Scholar · View at Scopus
  40. F. T. Liu, H. Goodarzi, and H. Y. Chen, “IgE, mast cells, and eosinophils in atopic dermatitis,” Clinical Reviews in Allergy and Immunology, vol. 41, no. 3, pp. 298–310, 2011. View at Publisher · View at Google Scholar · View at Scopus